Your browser doesn't support javascript.
loading
Vincristine/irinotecan/temsirolimus upfront window treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 Study Committee.
Thompson, Patrick A; Malogolowkin, Marcio H; Furman, Wayne L; Piao, Jin; Krailo, Mark D; Chung, Nadia; Brock, Lindsay; Towbin, Alexander J; McCarville, Elizabeth B; Finegold, Milton J; Ranganathan, Sarangarajan; Dunn, Stephen P; Langham, Max R; McGahren, Eugene D; Tiao, Gregory M; Weldon, Christopher B; O'Neill, Allison F; Rodriguez-Galindo, Carlos; Meyers, Rebecka L; Katzenstein, Howard M.
Afiliação
  • Thompson PA; North Carolina Children's Hospital and the University of North Carolina, Chapel Hill, North Carolina, USA.
  • Malogolowkin MH; University of California at Davis Comprehensive Cancer Center, Sacramento, California, USA.
  • Furman WL; University of Tennessee Health Science Center and St Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Piao J; University of Southern California Keck School of Medicine, Los Angeles, California, USA.
  • Krailo MD; University of Southern California Keck School of Medicine, Los Angeles, California, USA.
  • Chung N; Children's Oncology Group, Monrovia, California, USA.
  • Brock L; Children's Oncology Group, Monrovia, California, USA.
  • Towbin AJ; Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • McCarville EB; University of Tennessee Health Science Center and St Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Finegold MJ; Baylor College of Medicine, Houston, Texas, USA.
  • Ranganathan S; Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Dunn SP; Nemours Children's Hospital, Wilmington, Delaware, USA.
  • Langham MR; University of Tennessee Health Science Center and St Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • McGahren ED; University of Virginia Children's Hospital, Charlottesville, Virginia, USA.
  • Tiao GM; Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Weldon CB; Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.
  • O'Neill AF; Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.
  • Rodriguez-Galindo C; Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Meyers RL; Primary Children's Hospital, Salt Lake City, Utah, USA.
  • Katzenstein HM; Nemours Children's Hospital, Wilmington, Delaware, USA.
Pediatr Blood Cancer ; 70(7): e30365, 2023 07.
Article em En | MEDLINE | ID: mdl-37073741
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatoblastoma / Neoplasias Hepáticas Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Revista: Pediatr Blood Cancer Assunto da revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatoblastoma / Neoplasias Hepáticas Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Revista: Pediatr Blood Cancer Assunto da revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos